Mikhailidis DP - Search Results

1

Effect of ciprofibrate on lipoproteins, fibrinogen, renal function, and hepatic enzymes.

Rizos E, Bairaktari E, Ganotakis E, Tsimihodimos V, Mikhailidis DP, Elisaf M. Rizos E, et al. Among authors: mikhailidis dp. J Cardiovasc Pharmacol Ther. 2002 Oct;7(4):219-26. doi: 10.1177/107424840200700404. J Cardiovasc Pharmacol Ther. 2002. PMID: 12490967 Clinical Trial.

2

Low-molecular-weight heparin during instability in coronary artery disease.

Mikhailidis DP, Jagroop IA, Ganotakis E, Knight CJ, Goodall AH. Mikhailidis DP, et al. Lancet. 1996 Apr 27;347(9009):1191. doi: 10.1016/s0140-6736(96)90651-0. Lancet. 1996. PMID: 8609794 No abstract available.

3

Comment on: effect of pravastatin sodium and simvastatin on plasma fibrinogen level and blood rheology in type II hyperlipoproteinemia.

Mikhailidis DP, Ganotakis ES, Winder AF. Mikhailidis DP, et al. Atherosclerosis. 1996 Dec 20;127(2):287-90. doi: 10.1016/s0021-9150(96)05956-4. Atherosclerosis. 1996. PMID: 9125320 No abstract available.

4

Fibrinogen as a cardiovascular risk factor.

Breimer LH, Ganotakis ES, Mikhailidis DP. Breimer LH, et al. Among authors: mikhailidis dp. Rev Port Cardiol. 1997 Mar;16(3):245-50. Rev Port Cardiol. 1997. PMID: 9141902 Review. No abstract available.

5

Smoking, diabetes and hyperlipidaemia.

Mikhailidis DP, Papadakis JA, Ganotakis ES. Mikhailidis DP, et al. J R Soc Health. 1998 Apr;118(2):91-3. doi: 10.1177/146642409811800209. J R Soc Health. 1998. PMID: 10076642 Review.

6

Prothrombotic and lipoprotein variables in patients attending a cardiovascular risk management clinic: response to ciprofibrate or lifestyle advice.

Mikhailidis DP, Ganotakis ES, Spyropoulos KA, Jagroop IA, Byrne DJ, Winder AF. Mikhailidis DP, et al. Int Angiol. 1998 Dec;17(4):225-33. Int Angiol. 1998. PMID: 10204653

7

Statin + fibrate combination therapy fluvastatin with bezafibrate or ciprofibrate in high risk patients with vascular disease.

Papadakis JA, Ganotakis ES, Jagroop IA, Winder AF, Mikhailidis DP. Papadakis JA, et al. Among authors: mikhailidis dp. Int J Cardiol. 1999 Jun 1;69(3):237-44. doi: 10.1016/s0167-5273(99)00013-3. Int J Cardiol. 1999. PMID: 10402106

8

Effect of hypertension and its treatment on lipid, lipoprotein(a), fibrinogen, and bilirubin levels in patients referred for dyslipidemia.

Papadakis JA, Ganotakis ES, Jagroop IA, Mikhailidis DP, Winder AF. Papadakis JA, et al. Among authors: mikhailidis dp. Am J Hypertens. 1999 Jul;12(7):673-81. doi: 10.1016/s0895-7061(99)00049-7. Am J Hypertens. 1999. PMID: 10411364

9

Beneficial effect of moderate alcohol consumption on vascular disease: myth or reality?

Papadakis JA, Ganotakis ES, Mikhailidis DP. Papadakis JA, et al. Among authors: mikhailidis dp. J R Soc Promot Health. 2000 Mar;120(1):11-5. doi: 10.1177/146642400012000111. J R Soc Promot Health. 2000. PMID: 10918777 Review.

10

The effect of atorvastatin on serum lipids, lipoprotein(a) and plasma fibrinogen levels in primary dyslipidaemia--a pilot study involving serial sampling.

Goudevenos JA, Bairaktari ET, Chatzidimou KG, Milionis HJ, Mikhailidis DP, Elisaf MS. Goudevenos JA, et al. Among authors: mikhailidis dp. Curr Med Res Opin. 2001;16(4):269-75. doi: 10.1185/030079901750120204. Curr Med Res Opin. 2001. PMID: 11268711 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,418 results

Search Page

Filters